Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

The evolution of diagnosis and treatment of advanced nonsmall‐cell lung cancer (NSCLC) has led to increasing the use of targeted therapy and immune checkpoint inhibitors. The study goal was to assess the effect of molecular testing and the introduction of new therapies on overall survival (OS). All...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokoohi, Aria, Al‐Hashami, Zamzam, Moore, Sara, Pender, Alexandra, Wong, Selina K., Wang, Ying, Leung, Bonnie, Wu, Jonn, Ho, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704182/
https://www.ncbi.nlm.nih.gov/pubmed/34786889
http://dx.doi.org/10.1002/cam4.4427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704182/
https://www.ncbi.nlm.nih.gov/pubmed/34786889
http://dx.doi.org/10.1002/cam4.4427

Ejemplares similares